Litcius/Paper detail

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

Marie-Joëlle Jabagi, Jérémie Botton, Marion Bertrand, Alain Weill, Paddy Farrington, Mahmoud Zureik, Rosemary Dray‐Spira

2021JAMA142 citationsDOIOpen Access PDF

Abstract

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPulmonary embolismMyocardial infarctionPsychoanalysisGerontologyInternal medicineVirologyPsychologyDiseaseOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisViral Infections and Immunology Research
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older | Litcius